95 related articles for article (PubMed ID: 37710072)
1. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
2. The Role of Hyaluronan/Receptor for Hyaluronan-Mediated Motility Interactions in the Modulation of Macrophage Polarization and Cartilage Repair.
Bianchini E; Ashley Sin YJ; Lee YJ; Lin C; Anil U; Hamill C; Cowman MK; Kirsch T
Am J Pathol; 2024 Jun; 194(6):1047-1061. PubMed ID: 38403161
[TBL] [Abstract][Full Text] [Related]
3. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic Acid (HA) Receptors and the Motility of Schwann Cell(-Like) Phenotypes.
Ouasti S; Faroni A; Kingham PJ; Ghibaudi M; Reid AJ; Tirelli N
Cells; 2020 Jun; 9(6):. PubMed ID: 32560323
[TBL] [Abstract][Full Text] [Related]
5. The cytoskeletal protein RHAMM and ERK1/2 activity maintain the pluripotency of murine embryonic stem cells.
Jiang J; Mohan P; Maxwell CA
PLoS One; 2013; 8(9):e73548. PubMed ID: 24019927
[TBL] [Abstract][Full Text] [Related]
6. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy.
Nedvetzki S; Gonen E; Assayag N; Reich R; Williams RO; Thurmond RL; Huang JF; Neudecker BA; Wang FS; Turley EA; Naor D
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18081-6. PubMed ID: 15596723
[TBL] [Abstract][Full Text] [Related]
7. Enzyme variants in biosynthesis and biological assessment of different molecular weight hyaluronan.
Ebrahimi T; Keramati M; Khodabakhsh F; Cohan RA
AMB Express; 2024 May; 14(1):56. PubMed ID: 38730188
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan deposition during COVID-19 - helpful or harmful?
Hart D; Petri WA
Trends Mol Med; 2024 Mar; 30(3):207-208. PubMed ID: 38331701
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid metabolism and chemotherapy resistance: recent advances and therapeutic potential.
Liu Z; Hou P; Fang J; Shao C; Shi Y; Melino G; Peschiaroli A
Mol Oncol; 2023 Nov; ():. PubMed ID: 37953485
[TBL] [Abstract][Full Text] [Related]
10. Characterization, Bioactivity, and Biodistribution of 35 kDa Hyaluronan Fragment.
Gantumur MA; Jia X; Hui JH; Barber C; Wan L; Furenlid LR; Martin DR; Hui M; Liu Z
Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255712
[TBL] [Abstract][Full Text] [Related]
11. Effects of free fatty acid receptor (FFAR) signaling on the modulation of cancer cell functions under hypoxic conditions.
Yashiro N; Takai M; Yamamoto M; Amano Y; Hara K; Tsujiuchi T
Biochem Biophys Res Commun; 2024 Mar; 699():149554. PubMed ID: 38280308
[TBL] [Abstract][Full Text] [Related]
12. Intracellular pH regulates β-catenin with low pHi increasing adhesion and signaling functions.
Czowski BJ; White KA
bioRxiv; 2024 Mar; ():. PubMed ID: 38585883
[TBL] [Abstract][Full Text] [Related]
13. Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis.
Kouvidi K; Berdiaki A; Tzardi M; Karousou E; Passi A; Nikitovic D; Tzanakakis GN
Biochim Biophys Acta; 2016 Apr; 1860(4):814-24. PubMed ID: 26825774
[TBL] [Abstract][Full Text] [Related]
14. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
[TBL] [Abstract][Full Text] [Related]
15. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression.
Nikitovic D; Kouvidi K; Karamanos NK; Tzanakakis GN
Biomed Res Int; 2013; 2013():929531. PubMed ID: 24083250
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.
Samuel SK; Hurta RA; Spearman MA; Wright JA; Turley EA; Greenberg AH
J Cell Biol; 1993 Nov; 123(3):749-58. PubMed ID: 7693717
[TBL] [Abstract][Full Text] [Related]
17. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.
Shigeishi H; Higashikawa K; Takechi M
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1629-40. PubMed ID: 24676428
[TBL] [Abstract][Full Text] [Related]
18. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
